Drug · DIN 02558955
CORZYNA
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since June 30, 2025.
- Drug Identification Number (DIN)
- 02558955
- Company (DIN owner)
- Kye Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Ranolazine C01EB18
- Class
- Human
- Record last updated
- July 30, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RANOLAZINE | 750 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 30, 2025: NOC 35602Supplement to a New Drug Submission (SNDS) · Product Monograph reformatted to the Master Template. Addition of new strength: 375 and 750 mg. Addition of a manufacturing site and/or manufacturer involving production of the starting material. Addition of a drug product manufacturing site and/or manufacturer involving production. New package insert. New package labels
Other DINs named CORZYNA
- DIN 02510219 · Marketed
- DIN 02510227 · Marketed
- DIN 02558947 · Approved